Soon-Shiong invests in Toumaz; Cellnovo gets $48M to go global with diabetes management system;

> Mobile healthcare cheerleader (and angel investor) Dr. Patrick Soon-Shiong's firm, California Capital Equity, just purchased a more than 2 percent stake in wireless technology developer Toumaz of London. It may signal the beginning of a long-term play by Soon-Shiong, who just last week snapped up Vitality, the maker of the GlowCaps medication management system. Article 

> Clinical decision-support developer PEPID is launching a new iPad version of its application at HIMSS11. The app includes a drug database, dosage calculators, drug-interaction software and a symptom checker. Press release 

> Sherwin Krug, the CEO who just sold his company, to Healthagen, has already debuted a new company--TheDocClock. It allows patients to log and track wait times in physician offices and emergency rooms. Website  

> Cellnovo just received $48 million to go global with its mobile diabetes management system. The system consists of an insulin pump, mobile handset and diabetes management website for users. Article 

> Wondering if Lexi-Comp's iPad app is worth the nearly $300 annual price tag? iMedicalApps did an in-depth review and said overall, "yes." Post 

And Finally... Hopefully nobody had morning breath. Article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.